TPCN2 Activators are a collection of chemical compounds that enhance the functional activity of TPCN2 through various biochemical pathways. Nicotinic acid, through its action on GPR109A, indirectly augments TPCN2 activity by manipulating cAMP levels and thus promoting its role in sodium release in endolysosomal compartments. TPCN2 Activators encompass a spectrum of chemical entities that fine-tune the functional activity of TPCN2 within cellular signaling networks. Nicotinic acid, by activating GPR109A, modulates adenylate cyclase activity, reducing cAMP levels, and thereby potentially enhancing TPCN2's role in sodium release within endolysosomal systems. Pyridoxal phosphate, a cofactor in enzymatic processes, can influence cellular pH, indirectly modulating TPCN2's ion regulatory function in lysosomes. The manipulation of intracellular calcium through chelators like Fura-2 or modulators like Ryanodine impacts TPCN2, as its activity is calibrated by luminal calcium levels. Inhibitors such as Bafilomycin A1 and Monensin disrupt lysosomal acidification and sodium gradients, respectively, which could lead to an upsurge in TPCN2 activity aimed at re-establishing ionic equilibrium.
The delicate balance of sodium and calcium ions maintained by TPCN2 is further influenced by compounds that target other elements of the calcium signaling toolkit. NED-19, as a NAADP receptor antagonist, and Xestospongin C, an inhibitor of the IP3 receptor, both serve to modulate calcium release from acidic stores, indirectly amplifying TPCN2's role in endolysosomal signaling. Meanwhile, ML-SA1, by activating TRPML1, can elicit changes in lysosomal calcium efflux, which indirectly enhances TPCN2's activity. Each of these activators, through their targeted biochemical interventions, fosters an environment that necessitates or promotes the activation of TPCN2, ensuring that it plays its critical role in cellular ionic homeostasis without direct upregulation or modification of the protein itself. These chemicals, by tweaking various aspects of the cellular milieu, enable TPCN2 to maintain its pivotal function in the complex network of intracellular ion regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Nicotinic acid binds to and activates GPR109A, a G-protein-coupled receptor, which leads to the inhibition of adenylate cyclase and decreased cAMP levels. This can increase the activity of TPCN2 by promoting its role in endolysosomal sodium release. | ||||||
Pyridoxal-5-phosphate | 54-47-7 | sc-205825 | 5 g | $104.00 | ||
Pyridoxal phosphate serves as a cofactor for numerous enzymes, and its involvement in transamination reactions can affect cellular pH. The altered pH can potentially enhance the activity of TPCN2 as it regulates ion homeostasis in lysosomes. | ||||||
Indo 1 | 96314-96-4 | sc-215170 sc-215170A | 1 mg 5 mg | $162.00 $653.00 | ||
Fura-2 is a calcium indicator that can bind and chelate calcium ions, affecting calcium levels in the cell. By altering intracellular calcium concentrations, Fura-2 can indirectly enhance TPCN2 activity which is sensitive to luminal calcium levels. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine binds to ryanodine receptors and modulates calcium release from the sarcoplasmic/endoplasmic reticulum. This alteration in calcium dynamics can indirectly enhance TPCN2 activity, as it is influenced by cytosolic calcium levels. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 specifically inhibits V-ATPase, which can lead to an increase in lysosomal pH. Elevated pH within lysosomes may enhance TPCN2 function by promoting its role in restoring proton gradient through sodium/potassium exchange. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts sodium gradients across membranes. By altering sodium homeostasis, Monensin can indirectly increase the activity of TPCN2 as it functions to re-establish sodium equilibrium in lysosomal compartments. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a specific inhibitor of the Na+/K+-ATPase pump, leading to increased intracellular sodium levels. This could enhance TPCN2 activity, as TPCN2 may work to compensate for the disrupted sodium gradient and maintain ionic homeostasis. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
Xestospongin C is an inhibitor of the inositol trisphosphate receptor. By modulating IP3-mediated calcium release, it can indirectly enhance TPCN2 activity, as TPCN2 plays a role in calcium signaling and homeostasis in the lysosome. | ||||||